Omni Bioceutical Innovations Overview
- Founded
-
2014
- Status
-
Private
- Employees
-
11
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$810K
- Investors
-
2
Omni Bioceutical Innovations General Information
Description
Producer of treatment and care distillations intended to deliver innovative skin and hair treatments for a lifetime of dermatological and anti-aging needs. The company's distillations include nourishment for the skin, promoting collagen and elastin production as well as rejuvenation, nourishment, and assistance of hair health with proven scientific ingredients that send the correct bio-signals to the body's cells, enabling patients to renew, enhance and maintain skin and hair with ease.
Contact Information
Website
www.omnibioinnovations.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Personal Products
Other Industries
Biotechnology
Specialty Retail
Primary Office
- 7855 East Evans Road
- Suite C
- Scottsdale, AZ 85260
- United States
+1 (888) 000-0000
Omni Bioceutical Innovations Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Seed Round | 18-Dec-2015 | $810K | 00000 | 000.00 | Completed | Generating Revenue |
| 1. Grant | 19-May-2015 | 0000 | Completed | Generating Revenue |
Omni Bioceutical Innovations Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed 1 | 0,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 0.000 | |
| Seed | 00,000 | 00.000000 | 000.00 | 000.00 | 00 | 000.00 | 0.00 |
Omni Bioceutical Innovations Patents
Omni Bioceutical Innovations Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20220184026-A1 | Compositions of fulvic acid and cannabinoid and uses thereof | Pending | 04-Sep-2019 | 000000000 | |
| EP-3419634-A1 | Compositions of bioactive fulvate fractions and uses thereof | Pending | 26-Feb-2016 | 0000000000 | |
| AU-2016393867-B2 | Compositions of bioactive fulvate fractions and uses thereof | Active | 26-Feb-2016 | ||
| AU-2016393867-A1 | Compositions of bioactive fulvate fractions and uses thereof | Active | 26-Feb-2016 | 000000000 | |
| CA-3015458-A1 | Compositions of bioactive fulvate fractions and uses thereof | Pending | 26-Feb-2016 | A61K35/10 |
Omni Bioceutical Innovations Executive Team (4)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Jane Christensen | Co-Founder, Chairman, President and Chief Executive Officer | ||
| Cecil Hernandez | Treasurer |
Omni Bioceutical Innovations Board Members (4)
| Name | Representing | Role | Since |
|---|---|---|---|
| Jane Christensen | Omni Bioceutical Innovations | Co-Founder, Chairman, President and Chief Executive Officer | 000 0000 |
| Larry Davis | Omni Bioceutical Innovations | Board Member | 000 0000 |
| Maryann Guerra | Omni Bioceutical Innovations | Board Member | 000 0000 |
Omni Bioceutical Innovations Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Omni Bioceutical Innovations Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Drake Partners | Venture Capital | Minority | 000 0000 | 000000 0 | |
| BioAccel | Accelerator/Incubator | 000 0000 | 000000 0 |